A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Intensity Therapeutics, Inc.
Bristol-Myers Squibb
Second Affiliated Hospital of Guangzhou Medical University
Xencor, Inc.
Bristol-Myers Squibb
M.D. Anderson Cancer Center